Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

BACKGROUND: Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. METHODO...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig, Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110189/
https://www.ncbi.nlm.nih.gov/pubmed/21666749
http://dx.doi.org/10.1371/journal.pone.0020351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110189/
https://www.ncbi.nlm.nih.gov/pubmed/21666749
http://dx.doi.org/10.1371/journal.pone.0020351

Ejemplares similares